Octreotide in the treatment of malignant thymoma - Case report.

Rep Pract Oncol Radiother

Department of Oncology and Radiotherapy, Medical School and Teaching Hospital Pilsen, Charles University Prague, Czech Republic.

Published: August 2020

Unlabelled: Thymomas are the most common mediastinal tumors. Systemic therapy for patients with unresectable or recurrent thymomas is a challenging field in the current oncology research. There is some evidence that somatostatin analogs combined with corticosteroids may have a role in the treatment of advanced malignant thymoma; however, the role of these agents have not been fully evaluated.

Case Report: A 39-year-old man with metastatic thymoma was administered long-acting depot injection form of octreotide. Octreotide scan before the treatment initiation revealed low uptake. CT control after three months of the treatment revealed marked regression of pleural metastases, while the primary tumor mass remained stable. The treatment response was lasting for 9 months.

Conclusion: We describe an interesting case of marked clinical and radiological response of advanced malignant thymoma to the treatment with octreotide in a heavily pre-treated patient, even though octreotide scan revealed low uptake.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498848PMC
http://dx.doi.org/10.1016/j.rpor.2020.08.012DOI Listing

Publication Analysis

Top Keywords

malignant thymoma
12
advanced malignant
8
octreotide scan
8
revealed low
8
low uptake
8
octreotide
5
treatment
5
octreotide treatment
4
treatment malignant
4
thymoma
4

Similar Publications

[Analyses of the risk factors of delayed extubation after extended thymectomy in patients with myasthenia gravis].

Zhonghua Nei Ke Za Zhi

January 2025

Department of Thoracic Surgery, Xuanwu Hospital, Capital Medical University, Beijing100053, China.

To explore the risk factors of delayed extubation after expanded thymectomy in patients with myasthenia gravis. Patients with myasthenia gravis who underwent expanded thymectomy from May 2021 to January 2024 and were admitted to Intensive Care Unit (ICU) after surgery were retrospectively analyzed. Patients were divided in to the delayed extubation and successful extubation according to the length of mechanical ventilation whether exceeding than 48 hours.

View Article and Find Full Text PDF

Current immunotherapy for thymic epithelial tumors: a narrative review.

Mediastinum

October 2024

Department of General Thoracic Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.

Background And Objective: Thymic epithelial tumors (TETs) are the most common neoplasm of the prevascular mediastinal compartment and are characterized by their rarity and variable clinical presentation. The present study aimed to explore the current management of patients with TET with a special focus on immunotherapy for advanced disease.

Methods: Relevant studies published between 1981 and 2024 were searched in PubMed using search terms "Thymoma", "Thymic cancer", "Myasthenia gravis", "Radiation therapy", "Surgery", and "Immunotherapy".

View Article and Find Full Text PDF

Thymic epithelial tumors (TETs) are rare neoplasms that include thymomas, thymic carcinomas (TCs), and thymic neuroendocrine neoplasms (TNENs). These three tumor categories differ in aggressiveness, the incidence of recurrence after resection, the pattern of recurrence, and survival outcomes. Owing to the tumor's rarity, randomized trials have not been performed in the initial treatment setting.

View Article and Find Full Text PDF

Multimodal management and complete resection of invasive Type B3 thymoma with vascular reconstruction: a case report.

J Cardiothorac Surg

January 2025

Department of Thoracic Surgery, Guy's and St Thomas' NHS Foundation Trust, London, England.

Introduction: Thymomas and thymic carcinomas are rare anterior mediastinal tumours, accounting for 0.2-1.5% of all cancers.

View Article and Find Full Text PDF

Objectives: Detection of fat content in thymic lesions is essential to differentiate thymic hyperplasia from thymic tumors. This study assesses the reliability and efficacy of "iterative decomposition of water and fat with echo asymmetry and least-squares estimation quantization" IDEAL-IQ magnetic resonance sequence in distinguishing thymic hyperplasia from low-risk thymoma and thymic lymphoma in adulthood.

Methods: Thirty patients with thymic hyperplasia, 28 low-risk thymomas, and 13 thymic lymphomas were respectively enrolled.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!